- Home
- HFFG vs AARD Comparison
HFFG vs AARD Comparison
Compare HFFG & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HFFG | AARD |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | 960 | 40 |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.8M | 85.7M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | HFFG | AARD |
|---|---|---|
| Price | $1.87 | $4.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $6.00 | ★ $15.29 |
| AVG Volume (30 Days) | 129.2K | ★ 169.8K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.65 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,228,282,000.00 | N/A |
| Revenue This Year | $5.59 | N/A |
| Revenue Next Year | $2.24 | N/A |
| P/E Ratio | $92.00 | ★ N/A |
| Revenue Growth | ★ 2.21 | N/A |
| 52 Week Low | $1.38 | $3.35 |
| 52 Week High | $3.86 | $17.94 |
Technical Indicators
Market Signals| Indicator | HFFG | AARD |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 38.89 |
| Support Level | $1.73 | $3.35 |
| Resistance Level | $2.30 | $4.39 |
| Average True Range (ATR) | 0.10 | 0.48 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 14.75 | 16.47 |
Price Performance
Historical ComparisonAbout HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.